| COMPOSITION | |
|---|---|
| MEFTAL – MR Tablets | |
| Each Uncoated Tablet Contains: | |
| Mefenamic acid IP | 500 mg |
| Tizanidine HCl IP equivalent to Tizanidine | 2 mg |
| INDICATIONS | |
| MEFTAL-MR is indicated for short-term treatment of acute musculoskeletal disorders such as low backache, sprains, strains, sciatica, lumbago, torticollis occurring in adults. | |
| DOSAGE AND ADMINISTRATION | |
| Oral: The usual dose of MEFTAL-MR is one tablet to be taken three times daily with adequate amounts of water, preferably after food or snacks. The treatment lasts for 4-5 days. The drug is not to be continued for longer than seven days. | |
| HOW SUPPLIED | |
| 10 Tablets per strip. | |
